BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28524180)

  • 1. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
    Sung HY; Yang SD; Ju W; Ahn JH
    Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.
    Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH
    Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
    Sung HY; Ju W; Ahn JH
    Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
    Sung HY; Han J; Ju W; Ahn JH
    Oncol Rep; 2016 Jul; 36(1):535-41. PubMed ID: 27220283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
    Sung HY; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
    Sung HY; Yang SD; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.
    Sung HY; Choi EN; Lyu D; Park AK; Ju W; Ahn JH
    Oncol Rep; 2014 Aug; 32(2):815-20. PubMed ID: 24920423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
    Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion.
    Zou A; Liu R; Wu X
    Neoplasma; 2016; 63(6):865-872. PubMed ID: 27565324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2).
    Sizemore GM; Sizemore ST; Seachrist DD; Keri RA
    J Biol Chem; 2014 Aug; 289(35):24102-13. PubMed ID: 25012653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
    Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.
    Zafrakas M; Chorovicer M; Klaman I; Kristiansen G; Wild PJ; Heindrichs U; Knüchel R; Dahl E
    Int J Cancer; 2006 Mar; 118(6):1453-9. PubMed ID: 16187283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.